Cargando…
Wnt signaling pathway inhibitors, sclerostin and DKK-1, correlate with pain and bone pathology in patients with Gaucher disease
Patients with Gaucher disease (GD) have progressive bone involvement that clinically presents with debilitating bone pain, structural bone changes, bone marrow infiltration (BMI), Erlenmeyer (EM) flask deformity, and osteoporosis. Pain is referred by the majority of GD patients and continues to pers...
Autores principales: | Ivanova, Margarita M., Dao, Julia, Kasaci, Neil, Friedman, Andrew, Noll, Lauren, Goker-Alpan, Ozlem |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9730525/ https://www.ncbi.nlm.nih.gov/pubmed/36506070 http://dx.doi.org/10.3389/fendo.2022.1029130 |
Ejemplares similares
-
TRAP5b and RANKL/OPG Predict Bone Pathology in Patients with Gaucher Disease
por: Ivanova, Margarita, et al.
Publicado: (2021) -
Cellular and biochemical response to chaperone versus substrate reduction therapies in neuropathic Gaucher disease
por: Ivanova, Margarita M., et al.
Publicado: (2021) -
Rapid Clathrin-Mediated Uptake of Recombinant α-Gal-A to Lysosome Activates Autophagy
por: Ivanova, Margarita M., et al.
Publicado: (2020) -
Optimal therapy in Gaucher disease
por: Goker-Alpan, Ozlem
Publicado: (2010) -
Impaired autophagic and mitochondrial functions are partially restored by ERT in Gaucher and Fabry diseases
por: Ivanova, Margarita M., et al.
Publicado: (2019)